Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamran Ghoreschi

Showing results (1-10 of 201) with videos related to

Pageof 21
Sort By:
JAMA Dermatology|October 13, 2021
Targeting Immune Checkpoints and Cytokines to Protect From Psoriasis RelapseKamran Ghoreschi
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 31, 2016
Pathophysiologische Grundlagen der Systemtherapien bei PsoriasisSebastian Volc, Kamran Ghoreschi
Psoriasis (Auckland, N.Z.)|February 2, 2018
Update on the treatment of psoriasis and psoriatic arthritis - role of apremilastStephan Forchhammer, Kamran Ghoreschi
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 22, 2005
[Immunopathogenesis of psoriasis]Kamran Ghoreschi, Martin Röcken
Trends in Molecular Medicine|August 21, 2003
Molecular and cellular basis for designing gene vaccines against inflammatory autoimmune diseaseKamran Ghoreschi, Martin Röcken
Dermatology (Basel, Switzerland)|October 26, 2002
Phototherapy of sclerosing skin diseasesKamran Ghoreschi, Martin Röcken
Expert Review of Clinical Immunology|January 10, 2017
The role of IL-4 in psoriasisMatthias Hahn, Kamran Ghoreschi
Current Drug Targets. Inflammation and Allergy|June 8, 2004
Immune deviation strategies in the therapy of psoriasisKamran Ghoreschi, Martin Röcken
Dermatologie (Heidelberg, Germany)|August 30, 2024
[Janus kinase inhibitors for skin disorders]Farzan Solimani, Kamran Ghoreschi
Journal of Clinical Medicine|January 8, 2023
The Clinical Significance of Simultaneous IL-17A and IL-17F Blockade in Psoriasis Non-Responding to Anti-IL17A TherapyGeorgios Kokolakis, Kamran Ghoreschi
Pageof 21

Showing results (1-10 of 201) with videos related to

Sort By:
Pageof 21
JAMA Dermatology|October 13, 2021
Targeting Immune Checkpoints and Cytokines to Protect From Psoriasis RelapseKamran Ghoreschi
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 31, 2016
Pathophysiologische Grundlagen der Systemtherapien bei PsoriasisSebastian Volc, Kamran Ghoreschi
Psoriasis (Auckland, N.Z.)|February 2, 2018
Update on the treatment of psoriasis and psoriatic arthritis - role of apremilastStephan Forchhammer, Kamran Ghoreschi
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 22, 2005
[Immunopathogenesis of psoriasis]Kamran Ghoreschi, Martin Röcken
Trends in Molecular Medicine|August 21, 2003
Molecular and cellular basis for designing gene vaccines against inflammatory autoimmune diseaseKamran Ghoreschi, Martin Röcken
Dermatology (Basel, Switzerland)|October 26, 2002
Phototherapy of sclerosing skin diseasesKamran Ghoreschi, Martin Röcken
Expert Review of Clinical Immunology|January 10, 2017
The role of IL-4 in psoriasisMatthias Hahn, Kamran Ghoreschi
Current Drug Targets. Inflammation and Allergy|June 8, 2004
Immune deviation strategies in the therapy of psoriasisKamran Ghoreschi, Martin Röcken
Dermatologie (Heidelberg, Germany)|August 30, 2024
[Janus kinase inhibitors for skin disorders]Farzan Solimani, Kamran Ghoreschi
Journal of Clinical Medicine|January 8, 2023
The Clinical Significance of Simultaneous IL-17A and IL-17F Blockade in Psoriasis Non-Responding to Anti-IL17A TherapyGeorgios Kokolakis, Kamran Ghoreschi
Pageof 21